Literature DB >> 11277930

Processing of tumor necrosis factor by the membrane-bound TNF-alpha-converting enzyme, but not its truncated soluble form.

T Itai1, M Tanaka, S Nagata.   

Abstract

Tumour necrosis factor (TNF)-alpha-converting enzyme (TACE) is a membrane protein belonging to the ADAM (a disintegrin and metalloproteinase) family that cleaves various membrane proteins, including the proform of TNF-alpha. In this study, we constructed expression vectors for the membrane-bound full-length TACE (mTACE) and its truncated soluble form (sTACE). When a human TNF-alpha expression vector was introduced into human 293 cells, processing of TNF-alpha to its mature form was enhanced by coexpressing mTACE, and this processing was inhibited by a metalloproteinase inhibitor. On the other hand, coexpression of sTACE had no effect on the processing of TNF-alpha, although the culture medium of sTACE-transfected cells could cleave a peptide containing the TNF-alpha cleavage site. Fas ligand (FasL)-transfected 293 cells released a considerable amount of soluble FasL, and coexpression of neither mTACE nor sTACE enhanced this shedding. Immunoprecipitation and Western blotting analysis with cells that were cotransfected with TACE and TNF-alpha indicated that both mTACE and sTACE could interact with the proform of TNF-alpha. In the same assay, neither mTACE nor sTACE interacted with FasL. The catalytic domain-lacking TACE mutant, which could also interact TNF-alpha, showed a dominant negative effect on not only TNF-alpha secretion but also FasL secretion. These results suggest that binding of the membrane-anchored but not the soluble form of TACE to TNF-alpha results in efficient ectodomain shedding, and that FasL secretase is a metalloproteinase similar, but not identical, to TACE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277930     DOI: 10.1046/j.1432-1327.2001.02085.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

Review 1.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

2.  Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.

Authors:  Kaori Morimoto; Juri Horio; Haruhisa Satoh; Lucia Sue; Thomas Beach; Seizaburo Arita; Ikuo Tooyama; Yoshihiro Konishi
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor.

Authors:  Stefan Düsterhöft; Katharina Höbel; Mirja Oldefest; Juliane Lokau; Georg H Waetzig; Athena Chalaris; Christoph Garbers; Jürgen Scheller; Stefan Rose-John; Inken Lorenzen; Joachim Grötzinger
Journal:  J Biol Chem       Date:  2014-04-30       Impact factor: 5.157

4.  Mmp23b promotes liver development and hepatocyte proliferation through the tumor necrosis factor pathway in zebrafish.

Authors:  Fei Qi; Jianbo Song; Hanshuo Yang; Wei Gao; Ning-ai Liu; Bo Zhang; Shuo Lin
Journal:  Hepatology       Date:  2010-11-09       Impact factor: 17.425

Review 5.  The Role of ADAM17 in Inflammation-Related Atherosclerosis.

Authors:  Bai-Yi Tang; Jin Ge; Yang Wu; Juan Wen; Xiao-Hong Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-01       Impact factor: 4.132

Review 6.  ADAM 33 and its association with airway remodeling and hyperresponsiveness in asthma.

Authors:  Stephen T Holgate; Donna E Davies; Steuart Rorke; Julie Cakebread; Gillian Murphy; Robert M Powell; John W Holloway
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

Review 7.  TNFalpha blockade in human diseases: mechanisms and future directions.

Authors:  Maida Wong; David Ziring; Yael Korin; Sheetal Desai; Sungjin Kim; Jan Lin; David Gjertson; Jonathan Braun; Elaine Reed; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

Review 8.  The role of ADAM33 in the pathogenesis of asthma.

Authors:  Julie A Cakebread; H-M Haitchi; John W Holloway; Robert M Powell; Tim Keith; Donna E Davies; Stephen T Holgate
Journal:  Springer Semin Immunopathol       Date:  2003-11-15

9.  Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo.

Authors:  Minkyu L Kim; Bin Zhang; Ian P Mills; Marcos E Milla; Kurt R Brunden; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2008-11-12       Impact factor: 6.167

10.  Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Authors:  D Eads; Rl Hansen; Ao Oyegunwa; Ce Cecil; Ca Culver; F Scholle; Itd Petty; Sm Laster
Journal:  J Inflamm (Lond)       Date:  2009-01-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.